Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | RXRG | P48443 | 1/20 | 0.38 |
| ▸ | KCNK3 | O14649 | 3/20 | 0.37 |
| ▸ | KCNK9 | Q9NPC2 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29471353 | 1.00 | HTR7 (0.38) | HTR7GAARXRARXRBRXRG | |
| SCHEMBL9804688 | 0.82 | HTR7 (0.36) | HTR7L3MBTL1ALDH1A1CA1CA2 | |
| SCHEMBL3399136 | 0.82 | HTR7 (0.36) | HTR7L3MBTL1ALDH1A1CA1CA2 | |
| SCHEMBL4654446 | 0.82 | RXRA (0.47) | GAARXRARXRBRXRGKCNK3 | |
| SCHEMBL16184453 | 0.80 | MPL (0.44) | GAARXRARXRBRXRGKCNK3 | |
| SCHEMBL1619385 | 0.80 | MEN1 (0.36) | HTR7GAAL3MBTL1ALDH1A1CA1 | |
| SCHEMBL25310703 | 0.79 | KDM4E (0.34) | GAARXRARXRBRXRGKCNK3 | |
| SCHEMBL10874519 | 0.79 | MRGPRX4 (0.38) | L3MBTL1SCN9AALDH1A1 | |
| SCHEMBL5733587 | 0.79 | HSD11B1 (0.36) | KCNK3KCNK9L3MBTL1SCN9AALDH1A1 | |
| SCHEMBL4657366 | 0.79 | MPL (0.40) | GAARXRARXRBRXRGKCNK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 451 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112159329-B | Co-production preparation method of o-amino trifluoromethoxybenzene and m-amino trifluoromethoxybenzene | 大连奇凯医药科技有限公司 | 2022-09-06 | — | — | CN | claimed |
| US-12612380-B2 | Non-lysosomal glucosylceramidase inhibitors and uses thereof | ALECTOS THERAPEUTICS 1NC (CA) | 2026-04-28 | — | — | US | disclosed |
| EP-3966199-B1 | NON-LYSOSOMAL GLUCOSYLCERAMIDASE INHIBITORS AND USES THEREOF | ALECTOS THERAPEUTICS INC (CA) | 2026-03-18 | — | — | EP | disclosed |
| EP-4587014-A2 | C5AR1 ANTAGONISTS AND USES THEREOF | Vanqua Bio, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| US-20250214977-A1 | STAT6 INHIBITORS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2025-07-03 | — | — | US | disclosed |
| US-20250154193-A1 | STEROID COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Cholesgen (Shanghai) Co., Ltd. (CN) | 2025-05-15 | — | — | US | disclosed |
| EP-3870577-B1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | VIIV HEALTHCARE UK NO 5 LTD (GB) | 2025-03-19 | — | — | EP | disclosed |
| WO-2025043225-A2 | DEGRADERS OF CYCLIN-DEPENDENT KINASE 2 | GENENTECH, INC. (US) | 2025-02-27 | — | — | WO | disclosed |
| WO-2025021193-A1 | STEROID COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 珂阑(上海)医药科技有限公司 | 2025-01-30 | — | — | WO | disclosed |
| WO-2025020191-A1 | STEROID COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | 珂阑(上海)医药科技有限公司 | 2025-01-30 | — | — | WO | disclosed |
| EP-0130876-B1 | PROCESS FOR THE SIMULTANEOUS HALOGENATION AND FLUORINATION OF AROMATIC COMPOUNDS | RHONE-POULENC CHIMIE (FR) | 1988-04-20 | — | — | EP | disclosed |
| EP-0244328-A2 | Process for the preparation of aromatic aldehydes | RHONE-POULENC CHIMIE (FR) | 1987-11-04 | — | — | EP | disclosed |
| EP-0244329-A2 | Process for the preparation of aromatic aldehydes | RHONE-POULENC CHIMIE (FR) | 1987-11-04 | — | — | EP | disclosed |
| US-4575571-A | HALOGEN IN LIQUID HYDROGEN FLUORIDE | RHONE-POULENC SPECIALITES CHIMIQUES (FR) | 1986-03-11 | — | — | US | disclosed |
| US-4316994-A | Preparation of 4-fluoro-3-phenoxy-toluene | BAYER AKTIENGESELLSCHAFT (DE) | 1982-02-23 | — | — | US | disclosed |
| US-4311710-A | Anticoccidial formulation and method | ELI LILLY AND COMPANY (US) | 1982-01-19 | — | — | US | disclosed |
| US-4266082-A | Preparation of 4-fluoro-3-phenoxy-toluene | BAYER AKTIENGESELLSCHAFT (DE) | 1981-05-05 | — | — | US | disclosed |
| US-4259532-A | TRIFLUOROMETHOXYHALOPHENOL | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-03-31 | — | — | US | disclosed |
| US-4192669-A | DERIVATIVES OF 2-(4-(4-(TRIFLUOROMETHOXY)-PHENOXY)PHENOXY)AALKANOIC ACIDS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1980-03-11 | — | — | US | disclosed |
| US-4031119-A | LUBRICANTS, GREASES, SEALS | PONOMAREV ALEXEI IVANOVICH | 1977-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214977-A1 | STAT6 INHIBITORS AND USES THEREOF | STAT6, STAT5B, STAT5A | HTR7 3265/4885GAA 3260/4885RXRA 400/4885 |
| US-12612380-B2 | Non-lysosomal glucosylceramidase inhibitors and uses thereof | GBA1, GBA2, MAN2B1 | HTR7 4013/4885GAA 4/4885RXRA 4071/4885 |
| US-20250154193-A1 | STEROID COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SREBF1, SREBF2, CYP46A1 | HTR7 4039/4885GAA 1779/4885RXRA 551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.